|
⚲
|
| Keyboard |
| Rubin Eyal
✚
|
|
|---|---|
| CIK # | 0001721411 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001721411] | |
| 4 | [0001721411] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Rubin Eyal | |
| Nasus Pharma Ltd | |
| Protalix BioTherapeutics Inc | |
| Brainstorm Cell Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Protalix BioTherapeutics Inc PLX
Common Stock
|
2024-09-23 | Grant | 99,010 | ||
|
Protalix BioTherapeutics Inc PLX
Common Stock
|
2023-08-15 | Grant | 201,903 | ||
|
Protalix BioTherapeutics Inc PLX
Stock Options (Right to Buy) · derivative
|
2022-09-07 | Grant | 350,000 | $0.00 | |
|
Protalix BioTherapeutics Inc PLX
Common Stock
|
2022-02-25 | Grant | 121,951 | ||
|
Protalix BioTherapeutics Inc PLX
Common Stock
|
2020-08-11 | Grant | 246,146 | ||
|
Protalix BioTherapeutics Inc PLX
Stock Options (Right to Buy) · derivative
|
2019-09-22 | Grant | 800,000 | $0.00 | |
|
Brainstorm Cell Therapeutics Inc BCLI
Stock Option (right to buy) · derivative
|
2017-11-20 | Grant | 93,686 | $0.00 | |
|
Brainstorm Cell Therapeutics Inc BCLI
Common Stock
|
2017-11-20 | Grant | 25,000 | $0.00 |